pRB+/−/p53+/− mutant mice have been shown to acquire RET mutations that are analogous to activating germline mutations that are observed in human MEN2A and familial medullary thyroid carcinoma (FMTC). Here, RET is linked to multiple endocrine neoplasia type 2.